TLR7 activation in epilepsy of tuberous sclerosis complex

Area of Science:

• Neuroimmunology
• Epilepsy Pathophysiology
• Innate Immunity

Background:

• Neuroinflammation and toll-like receptors (TLRs) are implicated in epilepsy.
• MicroRNAs miR-142-3p and miR-223-3p are elevated in tuberous sclerosis complex (TSC) brain tissue.
• miR-142-3p activates toll-like receptor 7 (TLR7), a sensor of single-stranded RNA.

Purpose of the Study:

• To evaluate TLR7 expression and downstream interleukin-23A (IL23A) activation in surgically resected TSC brain tissue.
• To investigate the association between miR-142-3p and TLR7 activation in TSC-associated epilepsy.

Main Methods:

• Gene expression analysis of cortical tissue from TSC patients with pharmacoresistent epilepsy.
• NanoString nCounter assays and quantitative PCR for TLR expression and miR-142-3p levels.
• Assessment of TLR7 activation markers and protein expression via proteomics and Western blots.

Main Results:

• TLR7 transcript and signaling-competent protein were detected in all TSC specimens.
• TLR7 activation correlated with elevated neuroinflammation in epileptogenic lesions.
• TLR7 activity was significantly associated with tissue levels of miR-142-3p.

Conclusions:

• TLR7 activation by microRNAs may contribute to the neuroinflammatory cascade in TSC epilepsy.
• Further research may enable combined neuroimaging and TLR7 inhibitor therapies for intractable epilepsy.
• This pathway offers potential for personalized epilepsy treatment strategies.